Lasry, A., Nadorp, B., Loghavi, S., Patel, R., Mansour, H., Kelly, B., Walker, C., Buss, J., Boateng, I., Al-Santli, W., Ciantra, Z., Austin, R., Heyrosa, A., Desai, H., Laganson, A., Abaza, H., Procell, L., Patel, T., Kaffenberger, B., Wijeratne, S., Guillamot, M., Velegraki, M., Chiriboga, L., Li, Z., Abruzzo, L., Pollyea, D., McMahon, C., Shana'Ah, A., Byrd, J., Shih, A., Levine, R., Papapetrou, E., Tsirigos, A., Mardis, E., Mims, A., Aifantis, I., Eisfeld, A. (2025). Exploiting RAS pathway addiction as a therapeutic vulnerability in myeloid sarcoma. Blood. https://doi.org/10.1182/blood-2025-220